Background: Increased nuchal translucency (NT) is associated with aneuploidy. When the karyotype is normal, fetuses are still at risk for structural anomalies and genetic syndromes. Our study researched the diagnostic yield of prenatal microarray in a cohort of fetuses with isolated increased NT (defined as NT ≥ 3.5 mm) and questioned whether prenatal microarray is a useful tool in determining the adverse outcomes of the pregnancy. Materials and Methods: A prospective study was performed, in which 166 women, pregnant
OBJECTIVE: To evaluate the outcome of fetuses diagnosed to have increased nuchal translucency at the...
Nuchal translucency (NT) measurement between 11- and 14-weeks’ gestation is an established and consi...
We decided to asses the practicability of introducing nuchal translucency (NT) measurements as a scr...
Background: Increased nuchal translucency (NT) is associated with aneuploidy. When the karyotype is ...
Objectives To give an overview of the genetic and structural abnormalities occurring in fetuses with...
Background: To study the outcome of cases with nuchal translucency (NT) ≥ 95th centile in the first ...
OBJECTIVES: The objective of this study is to determine what percentage of fetal chromosomal anomali...
The aim was to evaluate first trimester nuchal translucency (NT) measurement for detection and risk ...
Introduction: Currently fetal nuchal translucency (NT) >= 3.5 mm is an indication for invasive testi...
Background: Thickened nuchal translucency (NT) has been related to fetal genetic syndromes, structur...
Objective To assess the value of increased nuchal translucency (NT ) at firsttrimester screening (FT...
Background: A significant number of pregnancies, particularly in women with previous histories of in...
This was a retrospective study done involving 434 patients in a university hospital over period of f...
Nuchal translucency (NT) measurement between 11 and 14 weeks' gestation is all undisputed marker for...
OBJECTIVES: To study the outcome of pregnancy in chromosomally normal fetuses with increased nuchal ...
OBJECTIVE: To evaluate the outcome of fetuses diagnosed to have increased nuchal translucency at the...
Nuchal translucency (NT) measurement between 11- and 14-weeks’ gestation is an established and consi...
We decided to asses the practicability of introducing nuchal translucency (NT) measurements as a scr...
Background: Increased nuchal translucency (NT) is associated with aneuploidy. When the karyotype is ...
Objectives To give an overview of the genetic and structural abnormalities occurring in fetuses with...
Background: To study the outcome of cases with nuchal translucency (NT) ≥ 95th centile in the first ...
OBJECTIVES: The objective of this study is to determine what percentage of fetal chromosomal anomali...
The aim was to evaluate first trimester nuchal translucency (NT) measurement for detection and risk ...
Introduction: Currently fetal nuchal translucency (NT) >= 3.5 mm is an indication for invasive testi...
Background: Thickened nuchal translucency (NT) has been related to fetal genetic syndromes, structur...
Objective To assess the value of increased nuchal translucency (NT ) at firsttrimester screening (FT...
Background: A significant number of pregnancies, particularly in women with previous histories of in...
This was a retrospective study done involving 434 patients in a university hospital over period of f...
Nuchal translucency (NT) measurement between 11 and 14 weeks' gestation is all undisputed marker for...
OBJECTIVES: To study the outcome of pregnancy in chromosomally normal fetuses with increased nuchal ...
OBJECTIVE: To evaluate the outcome of fetuses diagnosed to have increased nuchal translucency at the...
Nuchal translucency (NT) measurement between 11- and 14-weeks’ gestation is an established and consi...
We decided to asses the practicability of introducing nuchal translucency (NT) measurements as a scr...